| Literature DB >> 25787981 |
Timothy E Andrews1, Dan Wang, Daniel A Harki.
Abstract
The recognition that the persistence of cancer stem cells (CSCs) in patients following chemotherapy can result in disease relapse underscores the necessity to develop therapeutics against those cells. CSCs display a unique repertoire of cell surface macromolecules, which have proven essential for their characterization and isolation. Additionally, CSC-specific cell surface macromolecules or markers provide targets for the development of specific agents to destroy them. In this review, we compiled those cell surface molecules that have been validated as CSC markers for many common blood and solid tumors. We describe the unique chemical and structural features of the most common cell surface markers, as well as recent efforts to deliver chemotherapeutic agents into CSCs by targeting those macromolecules.Entities:
Year: 2013 PMID: 25787981 DOI: 10.1007/s13346-012-0075-1
Source DB: PubMed Journal: Drug Deliv Transl Res ISSN: 2190-393X Impact factor: 4.617